
Seelos Therapeutics SEEL
Quarterly report 2024-Q2
added 08-14-2024
Seelos Therapeutics PEG Ratio 2011-2026 | SEEL
Annual PEG Ratio Seelos Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.000266 | -0.000099 | 0.0342 | -0.0848 | -0.00539 | 0.000171 | 0.881 | -0.0294 | -0.0939 | 0.206 | -0.0806 | 0.0796 | -0.0862 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.881 | -0.0939 | 0.0631 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
0.0142 | $ 3.52 | -1.12 % | $ 1.05 B | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
0.108 | $ 3.25 | 3.83 % | $ 229 M | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M | ||
|
Aptorum Group Limited
APM
|
0.0951 | $ 0.8 | 1.27 % | $ 4.36 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
0.183 | $ 4.18 | -0.48 % | $ 105 M | ||
|
argenx SE
ARGX
|
0.081 | $ 715.26 | 1.7 % | $ 25 B | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
Ascendis Pharma A/S
ASND
|
-0.767 | $ 230.51 | -0.22 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.39 | -6.09 % | $ 8.16 B | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
-13.4 | $ 6.12 | 1.16 % | $ 499 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
0.0261 | $ 6.62 | -0.15 % | $ 181 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
0.0584 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
0.0443 | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
-0.0713 | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
BioCardia
BCDA
|
0.0271 | $ 1.36 | 7.09 % | $ 28.8 M | ||
|
Anika Therapeutics
ANIK
|
-0.431 | $ 14.64 | 1.92 % | $ 215 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-0.00128 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-0.00324 | $ 2.65 | 0.38 % | $ 16.6 M | ||
|
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 92.84 | 2.54 % | $ 27.2 B | ||
|
Autolus Therapeutics plc
AUTL
|
0.0906 | $ 1.5 | -0.66 % | $ 383 M | ||
|
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Burford Capital Limited
BUR
|
-0.568 | $ 8.28 | 2.73 % | $ 1.34 B | ||
|
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B | ||
|
Actinium Pharmaceuticals
ATNM
|
0.0965 | $ 1.15 | 3.6 % | $ 34.6 M |